Ari Melnick, MD, is the Gebroe Family Professor of Hematology/Oncology and a Professor of Medicine, Immunology and Pharmacology at Weill Cornell Medical College (WCMC) in New York City, USA. He is a leader in the field of lymphoma and leukemia experimental therapeutics, having developed multiple novel therapies to correct aberrant transcriptional regulation and signaling in these tumors. Dr. Melnick authored more than 300 published manuscripts in journals such as Nature, Science, Cell, Cancer Discovery, Cancer Cell, Nature Medicine, Nature Immunology, and the New England Journal of Medicine. He is a past ASH Faculty Scholar, LLS Scholar, Burroughs Wellcome Translational Research Scholar and Kimmel Foundation Scholar and is a member of the American Society for Clinical Investigation and the American Association of Physicians. He is an ICML Bonadonna Lecturer and recipient of the 2020 Beutler Lecture and Prize from the American Society of Hematology. He has organized and chaired many of the top level scientific meetings in the field for ASH, AACR, FASEB, etc.